No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
XOMA Corp - 8.375% DP PFD B Declares $0.5234 Dividend
Press Release: XOMA Royalty Declares Quarterly Preferred Stock Dividends
H.C. Wainwright Maintains XOMA Corp(XOMA.US) With Buy Rating, Maintains Target Price $123
H.C. Wainwright Maintains XOMA Corp(XOMA.US) With Buy Rating, Raises Target Price to $123
HC Wainwright & Co. Reiterates Buy on XOMA Royalty, Raises Price Target to $123
XOMA Royalty Shares Are Trading Higher After the Company Announced Its Economic Interest in Seralutinib, a Phase 3 Asset Studying Pulmonary Arterial Hypertension.